Doctor Devine on a growing number of patient concerns tied to GLP-1 use

More peptides

1. Medscape looks at retatrutide side effects reported by nearly 10,000 Reddit users

   

   MMedscape Oct 18

   peptides typeshitSafety

   Medscape looks at retatrutide side effects reported by nearly 10,000 Reddit users

   Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.

   See it on X
2. Gavin Coote reports on the social media boom in unregulated peptides

   

   FFacebook Oct 18

   peptides typeshitSafety

   Gavin Coote reports on the social media boom in unregulated peptides

   Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.

   See it on Facebook
3. Dr Bae says two deaths tied to bootleg retatrutide were reported to the FDA

   

   R@realdrbae Oct 18

   peptides typeshitSafety

   Dr Bae says two deaths tied to bootleg retatrutide were reported to the FDA

   A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.

   See it on Instagram
4. The Times hears from women who got pregnant while taking Mounjaro

   TTThe Times Oct 18

   peptides typeshitSafety

   The Times hears from women who got pregnant while taking Mounjaro

   One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.

   Read at The Times
5. AJC finds more than a dozen Georgia clinics selling unapproved retatrutide

   

   AJAtlanta Journal-Constitution Oct 15

   peptides typeshitLegal

   AJC finds more than a dozen Georgia clinics selling unapproved retatrutide

   The drug has no FDA approval yet, but the Atlanta Journal-Constitution found over a dozen medical facilities in Georgia selling it anyway.

   See it on X
6. Medscape revisits semaglutide eye stroke concerns 15 months after EU warning

   

   M@medscape Oct 15

   peptides typeshitSafety

   Medscape revisits semaglutide eye stroke concerns 15 months after EU warning

   European regulators flagged NAION, a sudden optic nerve injury, as a very rare possible side effect of semaglutide more than 15 months ago. Medscape looks at where that stands.

   See it on Instagram